MS DISEASE STATE
Drug
GENZYME CORPORATION
Total Payments
$507,765
Transactions
813
Doctors
468
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $13,486 | 352 | 246 |
| 2018 | $93,535 | 231 | 168 |
| 2017 | $400,745 | 230 | 178 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $421,671 | 5 | 83.0% |
| Grant | $56,000 | 28 | 11.0% |
| Food and Beverage | $28,005 | 740 | 5.5% |
| Consulting Fee | $1,088 | 1 | 0.2% |
| Travel and Lodging | $670.49 | 6 | 0.1% |
| Education | $330.44 | 33 | 0.1% |
Payments by Type
Research
$421,671
5 transactions
General
$86,094
808 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Study: Advancing Imaging Methods for Brian Glial Activation and its Correlates in MS | GENZYME CORPORATION | $291,500 | 0 |
| Advancing Imaging Methods for Brain Glial Activation and its Correlates in MS | GENZYME CORPORATION | $73,692 | 0 |
| Pacific Northwest Multiple Sclerosis Registry Collaboration: Outcomes by Disease Modifying Therapy Administration | GENZYME CORPORATION | $54,879 | 0 |
| MS: Patient poor adherence to disease modifying therapy and safety monitoring comprehensive analysis of factors contributing to this problem | GENZYME CORPORATION | $1,600 | 0 |
Top Doctors Receiving Payments for MS DISEASE STATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Portland, OR | $421,671 | 5 |
| , M.D | Neurology | Newport Beach, CA | $4,320 | 11 |
| , MD | Neurology | Phoenix, AZ | $4,274 | 5 |
| , M.D | Neurology | Billings, MT | $4,000 | 2 |
| Leo Maher | — | Honolulu, HI | $2,244 | 4 |
| , MD | Neurology | Seattle, WA | $2,203 | 2 |
| , MD | Neurology | Los Angeles, CA | $2,193 | 7 |
| , MD | Ophthalmology | Charleston, SC | $2,186 | 2 |
| , M.D | Neurology | Albany, NY | $2,110 | 2 |
| David Jones | Vascular Surgery | New York, NY | $2,064 | 2 |
| , D.O | Neurology | Highland Park, IL | $2,037 | 2 |
| , M.D | Neurology | Islip, NY | $2,022 | 2 |
| , MD, MA, PHD, MS | Spinal Cord Injury Medicine | Hackensack, NJ | $2,014 | 2 |
| , MD | Neurology | Columbus, OH | $2,014 | 2 |
| , MD | Neurology | Hershey, PA | $2,004 | 2 |
| , D.O | Neurology | Las Vegas, NV | $2,000 | 1 |
| , M.D | Neurology | Chicago, IL | $2,000 | 1 |
| , D.O | Neurology | Farmington Hills, MI | $2,000 | 1 |
| , M.D | Neurology | Columbus, OH | $2,000 | 1 |
| , MD | Neurology | Albuquerque, NM | $2,000 | 1 |
| , M.D | Neurology | Atlanta, GA | $2,000 | 1 |
| , MD | Vascular Neurology | Rochester, NY | $2,000 | 1 |
| , M.D | Neurology | Maywood, IL | $2,000 | 1 |
| , MD | Neurology | New Orleans, LA | $2,000 | 1 |
| , M.D | Neurology | Portland, OR | $2,000 | 1 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $507,326
- SANOFI-AVENTIS U.S. LLC $439.17
Product Information
- Type Drug
- Total Payments $507,765
- Total Doctors 468
- Transactions 813
About MS DISEASE STATE
MS DISEASE STATE is a drug associated with $507,765 in payments to 468 healthcare providers, recorded across 813 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2019. In 2019, $13,486 was paid across 352 transactions to 246 doctors.
The most common payment nature for MS DISEASE STATE is "Unspecified" ($421,671, 83.0% of total).
MS DISEASE STATE is associated with 4 research studies, including "Study: Advancing Imaging Methods for Brian Glial Activation and its Correlates in MS" ($291,500).